ABOUT PCM TRIALS
Since 2008, PCM Trials has led the way in mobile research. Our Certified Mobile Research Nurses (CMRNs) are driving the shift to patient-centric, decentralized clinical trials, giving individuals the flexibility to engage in research studies in the ways that work best for them and expanding opportunities for participation.
Our CMRN certification program, coupled with protocol-specific training, ensures that patients have the best possible study experience while sponsors meet their strategic development goals in the United States and internationally.
NEWS
-
PCM Trials, the largest independent mobile research nurse visit provider for decentralized clinical trials (DCTs), today announced the acquisition of EmVenio Research based in Durham, North Carolina.
-
PCM Trials, a Denver, USA based leader in providing mobile research nurses for decentralized clinical trials, today announced the acquisition of Clinical Trial Service (CTS).
FEATURED CONTENT
-
Discover how mobile visits revolutionize rare disease research, bridging gaps in clinical trial accessibility and enhancing patient engagement for conditions like Rett Syndrome.
-
As sponsors face regulatory pressure to include more pediatric patients in trials, could mobile nurse visits help them enroll more patients from this underrepresented group?
-
We analyze dropout data and speak to DCT expert Ellen Weiss to explore the power of mobile visits in improving patient engagement and retention rates.
-
Lowering barriers to participation could boost the diversity and inclusion of patients in clinical trials. Review this gender, race, and ethnicity data to understand the differences that mobile visits from a certified mobile research nurse can make.
-
As sponsors seek to minimize trial delays and get new therapies to market faster, explore whether increased adoption of a more patient-centric approach could make a difference to timelines.
-
When used in decentralized or hybrid clinical trials, find out how mobile nurses can significantly increase trial participant diversity and improve recruitment and retention.
-
Researchers, patients, pharma, and regulators face several obstacles when designing and conducting rare disease trials. Delve into the importance of home visits in rare disease clinical trials.
-
In mobile clinical trials, nurses are crucial in patient recruitment, screening, enrollment, data collection, and monitoring. Ensuring they're adequately trained in good clinical practice is essential.
-
New studies estimate DCTs deliver more than a five-fold return on investment due to reductions in clinical phase cycle times, decreases in screen failure rates, and fewer substantial protocol amendments.
-
Sponsors and CROs can utilize this checklist when aiming to achieve a successful decentralized trial or integration of a hybrid approach.
-
Discover how one mobile research services and clinical trials provider is addressing common concerns shared by CROs and sponsors regarding decentralized clinical trials.
-
Discover how demand for more patient-centric care drives continued popularity of using remote research nurses post pandemic.
CONTACT INFORMATION
PCM Trials
709 N Clarkson Street
Denver, CO 80218
UNITED STATES
FEATURED VIDEOS
-
Discover solutions to clinical trial challenges — this on-demand webinar by PCM Trials and Clinical Leader offers insights into the role of mobile nurse visits in overcoming patient dropout and trial delays.
-
In this presentation, speakers shed light on the advantages of home visits for clinical trials and what research nurses do to make this possible.
-
Dr. Steven Cummings highlights the role of PCM Trials certified mobile research nurses in making possible large-scale home-based clinical trial.
-
In this webinar featuring Ellen Weiss, vice president of in-home solutions for PCM Trials, learn how the pandemic has impacted the industry and what it means for CROs and sponsors now and moving forward.
FEATURED SOLUTIONS
-
When considering the clinical trial criteria, take the time to review how a fully decentralized approach using mobile research nurses could help advance your next drug development study.
-
Adaptable to any trial study, this team of experienced Certified Mobile Research Nurses travels directly to your trial participants, wherever they may be — at home, work, school, care centers, and more.
FEATURED CASE STUDIES
-
Explore the ways one double-blind, randomized Phase 3 study was able to boost the participant’s overall adherence to the protocol and increase their willingness to continue with the trial.
-
Learn how recruitment and screening of potential patients was made possible for a Phase 3, adult patients, clinical trial by utilizing MRUs to screen large volumes of patients at community events.
-
Gain insight from this Phase 3 global clinical trial focused on pre-clinical Alzheimer’s Disease where adult patients received one-hour intravenous infusions every month for 4.5 years.
-
The Trial of Parkinson’s and Zoledronic acid (TOPAZ) is seeking to enroll 3,500 participants over the age of 60, making it the largest double-blind, placebo-controlled, randomized clinical trial ever attempted in people with parkinsonism. Find out the approaches taken and the results in this case study.